About
Igor Vořechovský is a Czech-born geneticist known for his research into disease gene identification and processing of mature RNA precursors. He is the Emeritus Fellow of the University of Southampton. He lives in Hampshire, United Kingdom.
Research
Research groups
Research interests
- Disease gene identification
- Alternative RNA processing
Current research
Brief research history:
In the 1990’s, he contributed to the identification of important disease genes by positional cloning (examples in ref. 1-4). For example, he successfully used selection of complementary DNA by yeast artificial chromosomes that carried large pieces of human chromosome X to identify a gene for Bruton’s disease (1-3), immunodeficiency characterized by a lack of mature B cells and immunoglobulins and susceptibility to bacterial infections (5). These breakthrough studies led to a surge of functional investigations of newly identified proteins before the genome sequence became available and permitted molecular diagnostics of many diseases, including inherited cancer syndromes (6-7).
Later, he became interested in regulation of RNA processing, particularly gene splicing, with a plethora of publications studying the role of numerous splicing factors in this process. His group also investigated the impact of natural DNA variants, transposed elements and divalent metals on the splicing code, which controls cellular decisions if to remove intervening sequences from primary gene transcripts or not (8-12). As the Emeritus Fellow, he is still research active in this field (13).
Selected references
- Vorechovsky, I. et al. Isolation of cDNA clones mapping around DXS178: a search for human X-linked agammaglobulinaemia gene using yeast artificial chromosomes, cosmids and direct cDNA selection. Immunodeficiency 4, 221-224 (1993).
- Vetrie, D., Vorechovsky, I., et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226-233 (1993).
- Thomas, J.D. et al. Co-localization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261, 355-358 (1993).
- Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996).
- Bruton, O.C. Agammaglobulinemia. Pediatrics, 9, 722, 1952.
- Vorechovsky, I. et al. Molecular diagnosis of X-linked agammaglobulinaemia. Lancet 341, 1153 (1993).
- Vorechovsky, I., et al. Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: support for a gatekeeper mechanism in skin tumorigenesis. Cancer Res 57, 4677-4681 (1997).
- Kralovicova, J. et al. Branch site haplotypes that control alternative splicing. Hum Mol Genet 13, 3189-3202 (2004).
- Kralovicova, J. et al. Restriction of an intron size en route to endothermy. Nucleic Acids Res 49, 2460-2487 (2021).
- Pengelly, R. et al.. Exonic splicing code and protein binding sites for calcium. Nucleic Acids Res 50, 5493-5512 (2022).
- Vorechovsky, I. Transposable elements in disease-associated cryptic exons. Hum Genet 127, 135-154 (2010).
- Borovska, I. et al. Alu RNA fold links splicing with signal recognition particle proteins. Nucleic Acids Res 51, 8199-8216 (2023).
- Vorechovsky, I. From benign to pathogenic variants and vice versa: pyrimidine transitions at position -3 of TAG and CAG 3' splice sites. J Hum Genet 70, 125-133 (2025).
Research projects
Completed projects
Publications
Pagination
- 1
- 2
- 3
- 4
- 5
- …
-
Next page
Next
Biography
He studied medicine and molecular genetics at the Faculties of Medicine and Natural Sciences of the Purkynje University Brno (now Masaryk University). He graduated in 1983 cum laude. He earned a Doctor of Philosophy degree in cancer genetics (Charles University Prague). Between 1990 and 1995, he took fellowships at the Paterson Institute for Cancer Research, United Kingdom, and Karolinska Institute, Sweden. He then moved permanently to the United Kingdom where he worked at UCL and the University of Southampton. He was the Principal Research Fellow of the University until his retirement in 2024.